Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Scott L. Pomeroy, Marc Remke et al.|Acta Neuropathologica|2016Cited by 650
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in MedulloblastomaNataliya Zhukova, Rebecca M. Hill, Wiesława Grajkowska et al.|Journal of Clinical Oncology|2013Cited by 488
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG RegistriesLindsey M. Hoffman, Dominik Sturm, Sophie E. M. Veldhuijzen van Zanten et al.|Journal of Clinical Oncology|2018Cited by 433
Molecular Profiling Identifies Prognostic Subgroups of Pediatric Glioblastoma and Shows Increased YB-1 Expression in TumorsDamien Faury, Nada Jabado, André Nantel et al.|Journal of Clinical Oncology|2007Cited by 219
Anticancer Effects of Niclosamide in Human GlioblastomaAnja Wieland, Björn Scheffler, Daniel Trageser et al.|Clinical Cancer Research|2013Cited by 161